Susquehanna Fundamental Investments’s Elevance Health ELV Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,900	Closed	-$2.18M	–	438
2023 Q2	$2.18M	Hold	4,900	–	–	0.08%	232
2023 Q1	$2.25M	Sell	4,900 -6,900	-58%	-$3.28M	0.05%	347
2022 Q4	$6.05M	Sell	11,800 -190	-2%	-$96.5K	0.1%	251
2022 Q3	$5.45M	Buy	+11,990	New	+$5.74M	0.09%	305
2022 Q1	$25.8M	Buy	52,523 +6,900	+15%	+$3.15M	0.5%	23
2021 Q4	$21.1M	Sell	45,623 -500	-1%	-$210K	0.55%	24
2021 Q3	$17.2M	Sell	46,123 -14,196	-24%	-$5.4M	0.32%	60
2021 Q2	$23M	Buy	60,319 +28,717	+91%	+$11M	0.42%	33
2021 Q1	$11.3M	Sell	31,602 -28,039	-47%	-$9.02M	0.19%	137
2020 Q4	$19.1M	Buy	59,641 +7,439	+14%	+$2.28M	0.35%	47
2020 Q3	$14M	Buy	52,202 +7,702	+17%	+$2.07M	0.42%	25
2020 Q2	$11.7M	Buy	+44,500	New	+$11.9M	0.56%	23

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna Fundamental Investments's ELV Position: Q3 2023 in Review

Susquehanna Fundamental Investments sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 4,900 shares — an estimated $2.18M sold.

Susquehanna Fundamental Investments first reported a position in ELV in Q2 2020 and held it in 12 quarters. The position peaked at $25.8M in Q1 2022. 1,524 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

Susquehanna Fundamental Investments reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 4,900 Elevance Health shares in Q3 2023, an estimated $2.18M.
Susquehanna Fundamental Investments first reported a position in Elevance Health in Q2 2020 and held it in 12 quarters.
Susquehanna Fundamental Investments's Elevance Health position peaked at $25.8M in Q1 2022.
1,524 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2023, filed 14 Nov 2023.